window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 21, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Antimicrobial Resistance

  • Manufacturing & Supply Chain

    University Hospital Cologne selects Celonic for anti-Pseudomonas antibody manufacturing

    University Hospital Cologne has selected Celonic as its CDMO partner [...]

    August 13, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Calla Lily selected for $50M Wellcome Leap antibiotic programme

    Calla Lily Clinical Care has been selected for Wellcome Leap’s [...]

    August 12, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Kupando doses first patient in Phase 1 trial of KUP101 for advanced skin cancer

    Kupando has dosed the first patient in a Phase 1 [...]

    August 7, 2026
  • Digital & Data,Research & Development,Therapeutic Areas

    Fleming Initiative selects AWS to support global antimicrobial resistance platform

    The Fleming Initiative has selected Amazon Web Services (AWS) to [...]

    July 3, 2026
  • Digital & Data,Drug Discovery & Development,Research & Development

    Basecamp integrates AI antibiotic and vaccine design models into Claude Science

    Basecamp Research has integrated its EDEN antibiotic design and vaccine [...]

    July 2, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    AMR Action Fund leads €18M Series A for Telum Therapeutics

    Telum Therapeutics has raised €18 million in a Series A [...]

    July 2, 2026
  • Clinical & Regulatory,Medical devices,Therapeutic Areas

    Laser therapy reduces bacterial load in burn wounds, study shows

    A single photobiomodulation session reduced bacterial load in acute burn [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    PACE launches third funding round to tackle antimicrobial resistance and support innovative therapeutics

    PACE (Pathways to Antimicrobial Clinical Efficacy) has launched its third [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas

    Shionogi and BioVersys agree €498M licensing deal for NTM drug candidates

    Deal gives Shionogi access to BioVersys’ BV500 program targeting serious [...]

    May 5, 2026
  • Drug Discovery & Development

    Study shows bifunctional immunotherapy clears MDR Gram-negative bacteria in preclinical models

    CTX-09 demonstrates immune-mediated efficacy through Alphamer platform, supporting immune system [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Sapience Therapeutics gets FDA clearance for ST316 FAP study
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • EURneffy recommended for emergency anaphylaxis treatment in NHS Wales
    Categories: Clinical & Regulatory, Drug Delivery & Formulation, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Lifebit awarded three-year NIHR BioResource research environment contract
    Categories: Biotech & Pharma Business, Digital & Data, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top